Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.

Source:http://linkedlifedata.com/resource/pubmed/id/19471949

Download in:

View as

General Info

PMID
19471949